60
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Determinants of airflow limitation in Danish adults – findings from the Health2006 cohort

, , &
Pages 713-718 | Published online: 26 Mar 2019

References

  • HansenJGPedersenLOvervadKOmlandØJensenHKSørensenHTThe prevalence of chronic obstructive pulmonary disease among Danes aged 45–84 years: population-based studyCOPD20085634735219353348
  • BackerVLykkegaardJBodtgerUAgertoftLKorshoejLBraünerEVThe Danish national database for asthmaClin Epidemiol2016860160627822106
  • AliZDirksCGUlrikCSLong-term mortality among adults with asthma: a 25-year follow-up of 1,075 outpatients with asthmaChest201314361649165523471206
  • PanizzaJAJamesALRyanGde KlerkNFinucaneKEMortality and airflow obstruction in asthma: a 17-year follow-up studyIntern Med J2006361277378017096740
  • SantibáñezMGarrastazuRRuiz-NuñezMPredictors of hospitalized exacerbations and mortality in chronic obstructive pulmonary diseasePLoS One2016116e015872727362765
  • HuangSVasquezMMHalonenMMartinezFDGuerraSAsthma, airflow limitation and mortality risk in the general populationEur Respir J201545233834625323227
  • AnthonisenNRConnettJEMurrayRPSmoking and lung function of lung health study participants after 11 yearsAm J Respir Crit Care Med2002166567567912204864
  • GodtfredsenNSLamTHHanselTTCOPD-related morbidity and mortality after smoking cessation: Status of the evidenceEur Respir J200832484485318827152
  • CalverleyPMAAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
  • TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
  • VestboJAndersonJABrookRDFluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (Summit): a double-blind randomised controlled trialLancet2016387100301817182627203508
  • DijkstraAVonkJMJongepierHLung function decline in asthma: association with inhaled corticosteroids, smoking and sexThorax200661210511016308336
  • LangePScharlingHUlrikCSVestboJInhaled corticosteroids and decline of lung function in community residents with asthmaThorax200661210010416443705
  • HaahtelaTJärvinenMKavaTComparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthmaN Engl J Med199132563883922062329
  • HaahtelaTTamminenKKavaTThirteen-year follow-up of early intervention with an inhaled corticosteroid in patients with asthmaJ Allergy Clin Immunol200912461180118520004779
  • AgertoftLPedersenSEffects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic childrenRespir Med19948853733818036306
  • ThuesenBHCerqueiraCAadahlMCohort profile: the Health2006 cohort, research centre for prevention and healthInt J Epidemiol201443256857523615486
  • LøkkeAUlrikCSDahlRDetection of previously undiagnosed cases of COPD in a high-risk population identified in general practiceCOPD20129545846522643016
  • AadahlMZachoMLinnebergAThuesenBHJørgensenTComparison of the Danish step test and the watt-max test for estimation of maximal oxygen uptake: the Health2008 studyEur J Prev Cardiol20132061088109423022702
  • Boyano MartínezTGarcía-AraCDíaz-PenaJMMuñozFMGarcía SánchezGEstebanMMValidity of specific IgE antibodies in children with egg allergyClin Exp Allergy20013191464146911591198
  • DreborgSDiagnosis of food allergy: tests in vivo and in vitroPediatr Allergy Immunol200112Suppl 14243011380894
  • MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J200526231933816055882
  • QuanjerPHTammelingGJCotesJEPedersenOFPeslinRYernaultJCLung volumes and forced ventilatory flows. Report Working Party standardization of lung function tests, European community for steel and coal. OFFICIAL statement of the European Respiratory SocietyEur Respir J Suppl1993165408499054
  • American ThoracicSEuropean RespiratorySATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005Am J Respir Crit Care Med2005171891293015817806
  • World Health OrganizationThe WHO Global Database on BMI2018Geneva, SwitzerlandBMI Classification2018
  • HankinsonJLOdencrantzJRFedanKBSpirometric reference values from a sample of the general U.S. populationAm J Respir Crit Care Med199915911791879872837
  • KharitonovSARobbinsRAYatesDKeatingsVBarnesPJAcute and chronic effects of cigarette smoking on exhaled nitric oxideAm J Respir Crit Care Med199515226096127543345
  • Ten BrinkeAZwindermanAHSterkPJRabeKFBelEHFactors associated with persistent airflow limitation in severe asthmaAm J Respir Crit Care Med2001164574474811549526
  • SeeKCChristianiDCNormal values and thresholds for the clinical interpretation of exhaled nitric oxide levels in the US general population: results from the National Health and Nutrition Examination Survey 2007–2010Chest2013143110711622628492
  • BommaritoLMiglioreEBugianiMExhaled nitric oxide in a population sample of adultsRespiration200875438639217596680
  • MatsunagaKHiranoTOkaAItoKEdakuniNPersistently high exhaled nitric oxide and loss of lung function in controlled asthmaAllergol Int201665326627126822895
  • HiranoTMatsunagaKSugiuraHPersistent elevation of exhaled nitric oxide and modification of corticosteroid therapy in asthmaRespir Investig20135128491
  • TayTChooXIhsanRTohHPWongHSTeeACharacteristics of non-smoking adult asthma patients with chronic airflow limitationJ Asthma201754101026103228332897
  • GOLDGlobal Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease2018 Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdfAccessed March 20, 2019
  • NakaoMYamauchiKIshiharaYOmoriHSolongoBIchinnorovDPrevalence and risk factors of airflow limitation in a Mongolian population in Ulaanbaatar: cross-sectional studiesPLoS One2017124e017555728399185
  • UlrikCSLangePCigarette smoking and asthmaMonaldi Arch Chest Dis200156434935311770219
  • HolguinFBleeckerERBusseWWObesity and asthma: an association modified by age of asthma onsetJ Allergy Clin Immunol2011127614861493.e221624618
  • RasmussenFHancoxRJMechanisms of obesity in asthmaCurr Opin Allergy Clin Immunol2014141354324300417
  • ÇolakYMarottJLVestboJLangePOverweight and obesity may lead to under-diagnosis of airflow limitation: findings from the Copenhagen City Heart studyCOPD201512151325290888
  • CanoyDLubenRWelchAAbdominal obesity and respiratory function in men and women in the EPIC-Norfolk study, United KingdomAm J Epidemiol2004159121140114915191931
  • TchernofADesprésJ-PPathophysiology of human visceral obesity: an updatePhysiol Rev201393135940423303913
  • O’DonnellDECiavagliaCENederJAWhen obesity and chronic obstructive pulmonary disease collide. Physiological and clinical consequencesAnn Am Thorac Soc201411463564424625243
  • BouletL-Pdes CormiersAThe link between obesity and asthma: a Canadian perspectiveCan Respir J200714421722017551597